4
Changes in Ownership
Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-002173
Director bought 433 shares at an average $2.88 ($1,247)
From the SEC's structured data for this filing
Trades in this filing
Maryles Joel Michael · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-24 | Purchase : show line 1 in the form | +400 | $2.89 | $1,156 | 1,400 | D |
| 2022-05-24 | Purchase : show line 2 in the form | +33 | $2.76 | $91 | 1,433 | D |
| Open-market purchases · 433 sh · avg $2.88 · $1,247 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-07 | Grant or award : show line 3 in the form Option to Purchase American Depositary Shares | +6,820 | 6,820 | D |
| 2021-04-19 | Grant or award : show line 4 in the form Option to Purchase American Depositary Shares | +11,884 | 11,884 | D |
Loading xslF345X03/zk2227908.xml…